Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Food Safety Testing Labs Evaluate PathoGenetix Microbial Strain Typing System

Published: Friday, November 29, 2013
Last Updated: Friday, November 29, 2013
Bookmark and Share
Company is developing a fully automated bacterial identification system to improve time-to-results for pathogen confirmation and strain typing in food safety testing and foodborne illness outbreak investigations.

PathoGenetix, Inc. has announced that it has completed the first round of customer evaluations for its RESOLUTION™ Microbial Genotyping System. The RESOLUTION Customer Experience Program gives key prospects in critical target markets a hands-on, in-depth review of the company’s rapid bacterial identification system, and is an important step in the commercialization of the System, which will be available in 2014 for use in food safety testing and foodborne illness outbreak investigations.

The RESOLUTION Customer Experience Program enables potential customers to visit PathoGenetix and participate in a two-day workshop that provides a detailed review of the RESOLUTION Microbial Genotyping System including hands-on time with the instrument, bioinformatics software and database, and pathogen-specific assays for Salmonella and E. coli.

Customer feedback on user requirements, utility and ease-of-use of the System is also a key component of the Program.

PathoGenetix’s first round of onsite evaluations focused on leading contract testing labs serving the food safety market. Many food producers worldwide rely on third party contract laboratories for all or part of their food quality and safety testing programs.

Wisconsin-based Marshfield Food Safety, LLC, was one of five contract testing laboratories to visit PathoGenetix in October and November for the RESOLUTION Customer Experience Program. Marshfield provides full service microbiology and chemistry testing and food safety risk management services to clients along the food chain from farm to table.

Marshfield CEO, Roy Radcliff, PhD, said of the potential impact of the RESOLUTION System on food safety testing, “The RESOLUTION System could change how pathogen confirmations are performed in testing laboratories. The ability to identify and differentiate multiple serotypes from a single sample could give our customers the ability to quickly identify sources of contamination and track specific organisms through a production facility.”

“The RESOLUTION Customer Experience Program provides important input for PathoGenetix as we develop our innovative technology into a powerful new food safety solution for the food industry and public health agencies,” said John Czajka, PhD, PathoGenetix’s Vice President of Business Development. “By offering industry experts the opportunity to work with the RESOLUTION System, they have been able to see first-hand both the simplicity of the System and its exceptional pathogen characterization capabilities. PathoGenetix has been able to get detailed customer feedback that will enable us to fine tune the System to further match end-user requirements and existing laboratory workflows.”

PathoGenetix will be offering the RESOLUTION Customer Experience Program again in 2014, with a focus on food production companies that conduct food safety testing in-house.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Fix for 3-Billion-Year-Old Genetic Error
Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time.
“Amazing Protein Diversity” Discovered in Maize
The genome of the corn plant – or maize, as it’s called almost everywhere except the US – “is a lot more exciting” than scientists have previously believed. So says the lead scientist in a new effort to analyze and annotate the depth of the plant’s genetic resources.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!